Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $9000.0.

  • ImmunoTech's Depreciation & Amortization (CF) fell 1000.0% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $37000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $37000.0 for FY2024, which is 512.82% down from last year.
  • According to the latest figures from Q3 2025, ImmunoTech's Depreciation & Amortization (CF) is $9000.0, which was down 1000.0% from $9000.0 recorded in Q2 2025.
  • ImmunoTech's Depreciation & Amortization (CF)'s 5-year high stood at $11000.0 during Q1 2023, with a 5-year trough of $9000.0 in Q3 2023.
  • In the last 3 years, ImmunoTech's Depreciation & Amortization (CF) had a median value of $9000.0 in 2023 and averaged $9454.5.
  • The largest annual percentage gain for ImmunoTech's Depreciation & Amortization (CF) in the last 5 years was 1111.11% (2024), contrasted with its biggest fall of 1818.18% (2024).
  • Over the past 3 years, ImmunoTech's Depreciation & Amortization (CF) (Quarter) stood at $9000.0 in 2023, then changed by 0.0% to $9000.0 in 2024, then changed by 0.0% to $9000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $9000.0 for Q3 2025, versus $9000.0 for Q2 2025 and $10000.0 for Q1 2025.